From: Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer
Biomarkers HR (95% CI), n = 50 | Multivariable model of OS | P | Multivariable model of PFS | P |
---|---|---|---|---|
PBLC (prior to ICIs) | 0.280(0.095–0.823) | 0.021 | 0.413(0.141–1.213) | 0.108 |
Adjusted PBLC (prior to ICIs) | 0.482(0.233–0.999) | 0.049 | 0.693(0.337–1.426) | 0.319 |
PBLC (post treatment) | 0.459(0.148–1.422) | 0.177 | 0.791(0.285–2.422) | 0.681 |
NLR | 1.150(1.052–1.257) | 0.002 | 1.086(1.002–1.177) | 0.045 |
Adjusted NLR | 2.575(1.217–5.447) | 0.013 | 2.189(1.085–4.414) | 0.029 |
MLR | 3.880(0.665–22.626) | 0.132 | 3.433(0.610-19.327) | 0.162 |
Adjusted MLR | 1.802(0.858–3.787) | 0.120 | 1.619(0.802–3.271) | 0.179 |
PLR | 1.004(1.000-1.008) | 0.028 | 1.002(0.999–1.006) | 0.161 |
Adjusted PLR | 1.596(0.714–3.568) | 0.255 | 1.596(0.709–3.593) | 0.259 |
ICIs lines | 1.929(1.289–2.887) | 0.001 | 2.778(1.819–4.241) | 0.00 |
Age | 1.007(0.959–1.057) | 0.784 | 1.075(1.011–1.143) | 0.021 |